(Q34366450)

1 August 2017

1 reference

title

Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens (English)

1 reference

1 August 2017

1 reference

Pirofski LA

1

1 reference

1 August 2017

publication date

1 September 2001

1 reference

1 August 2017

published in

Trends in Microbiology

1 reference

1 August 2017

volume

9

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

445-451

1 reference

Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Cryptococcus neoformans: paradigm for the role of antibody immunity against fungi?

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

T cell-independent antigens type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of V(H)3 gene segment usage

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Haemophilus influenzae type b bacteremia in adults with AIDS and at risk for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Immunoglobulin V H 3 Gene Products: Natural Ligands for HIV gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Use of licensed vaccines for active immunization of the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Immunoglobulin VH gene expression in human aging

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Aberrant V(H) gene utilization in patients with established insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

A B cell superantigen-induced persistent "Hole" in the B-1 repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

IgG response to pneumococcal polysaccharide-protein conjugate appears similar to IgG response to polysaccharide in bone marrow transplant recipients and healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Immunoregulation by capsular components of Cryptococcus neoformans.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Opsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomannan antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Dispute slows paper on "remarkable" vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Canonical structure repertoire of the antigen-binding site of immunoglobulins suggests strong geometrical restrictions associated to the mechanism of immune recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Searching for Peptide Ligands with an Epitope Library

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Discovering peptide ligands using epitope libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Peptide mimicry of the meningococcal group C capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

From absolute to exquisite specificity. Reflections on the fuzzy nature of species, specificity and antigenic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Molecular basis for the lack of mimicry of Brucella polysaccharide antigens by Ab2gamma antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induce functional anti-carbohydrate antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Crossreactivity of mimotopes and peptide homologues of a sequential epitope with a monoclonal antibody does not predict crossreactive immunogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

A molecular basis for functional peptide mimicry of a carbohydrate antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

Are there two distinct research strategies for developing biologically active molecules: rational design and empirical selection?

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2801%2902134-5

7 January 2021

10.1016/S0966-842X(01)02134-5

Identifiers

DOI

1 reference

1 August 2017

1 reference